Allurion Technologies (ALURW) Common Equity (2022 - 2026)

Allurion Technologies (ALURW) has 5 years of Common Equity data on file, last reported at -$77.9 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 11.63% year-over-year to -$77.9 million; the trailing twelve-month figure through Mar 2026 stood at -$77.9 million (down 11.63% YoY), and the FY2025 full-year result was -$77.2 million, up 1.01% from the prior year.
• Common Equity for Q1 2026 stood at -$77.9 million, down from -$77.2 million in the prior quarter.
• Across five years, Common Equity topped out at -$6.7 million in Q2 2022 and bottomed at -$82.9 million in Q3 2025.
• The 5-year median for Common Equity is -$68.0 million (2024), against an average of -$59.7 million.
• The widest annual swing landed in 2023, when Common Equity plunged 962.0%; it then increased 9.36% in 2025.
• A 5-year view of Common Equity shows it stood at -$32.3 million in 2022, then slumped by 120.64% to -$71.3 million in 2023, then declined by 9.37% to -$78.0 million in 2024, then advanced by 1.01% to -$77.2 million in 2025, then decreased by 0.93% to -$77.9 million in 2026.
• The last three Common Equity figures came in at -$77.9 million (Q1 2026), -$77.2 million (Q4 2025), and -$82.9 million (Q3 2025), per Business Quant data.

Peer Comparison